Genetic progression and clonal relationship of recurrent premalignant head and neck lesions

Clinical Cancer Research

Volumn 6, Issue 2, 2000, Pages 347-352

  Califano, Joseph ^a   Westra, William H ^a   Meininger, Glenn ^a   Corio, Russel ^a   Koch, Wayne M ^a   Sidransky, David ^a,b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b Div of Hd and Neck Cancer Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA;

ARTICLE; AUTORADIOGRAPHY; CHROMOSOME ARM; GENE MUTATION; GENETIC ANALYSIS; HEAD CANCER; HETEROZYGOSITY LOSS; HUMAN; NECK CANCER; PHENOTYPE; PRECANCER; PRIORITY JOURNAL;

BIOPSY; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 8; CHROMOSOMES, HUMAN, PAIR 9; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; NEOPLASM RECURRENCE, LOCAL; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES;

EID: 0033966575     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
2. Califano, J., van der Riet, P., Westra, W., Nawroz, H., Clayman, G., Piantadosi, S., Corio, R., Lee, D., Greenberg, B., Koch, W., and Sidransky, D. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 56: 2488-2492, 1996.
3. Kamb, A., Gruis, N., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tautigan, S. V., Stockert, E., Day, R. S., III, Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science, (Washington DC), 264: 436-440, 1994.
4. Nabori, T., Miura, K., Wu, D., Lois, A., Takahayashi, K., and Carson, D. A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368: 753-756, 1994.
5. Nawroz, H., van der Riet, P., Hruban, R. H., Koch, W. M., Ruppert, J. M., and Sidransky, D. Allelotype of head and neck squamous cell carcinoma. Cancer Res., 54: 1152-1155, 1994.
6. Reed, A. L., Califano, J., Cairns, P., Westra, W. H., Jones, R. M., Koch, W., Ahrendt, S., Eby, Y., Sewell, D., Nawroz, H., Bartek, J., and Sidransky, D. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res., 56: 3630-3633, 1996.
7. Callender, T., El-Naffar, A. K., Lee, M., Frankenthaler, R., Luna, M. A., and Batsakis, J. G. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer (Phila.), 74: 152-158, 1994.
8. Lese, C. M., Rossie, K. M., Appel, B. N., Reddy, J. K., Johnson, J. T., Myers, E. W., and Gollin, S. M. Visualization of Int2 and Hst1 amplification in oral squamous cell carcinomas. Genes Chromosomes Cancer, 12: 288-295, 1995.
9. Boyle, J. O., Hakim, J., Koch, W., van der Riet, P., Hruban, R. H., Roa, R. A., Correo, R., Eby, Y. J., Ruppert, J. M., and Sidranski, D. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res., 53: 4477-4480, 1994.
10. Wu, C. L., Sloane, P., Read, A. P., Harris, R., and Thakker, N. Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity. Cancer Res., 54: 6484-6488, 1994.
11. Maestro, R., Gasparotto, D., Vuksavljevic, T., Barzan, L., Sulfaro, S., and Biocchi, M. Three discrete regions of deletion in head and neck cancers. Cancer Res., 53: 5775-5779, 1993.
12. Yoo, G. H., Xu, H. J., Brennan, J. A., Westra, W., Hruban, R. H., Koch, W., Benedict, W. F., and Sidransky, D. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res., 54: 4603-4606, 1994.
13. Rosin, M. P., Epstein, J. B., Berean, K., Durham, S., Hay, J., Cheng, X., Zeng, T., Huang, Y., and Zhang, L. The use of exfoliative cell samples to map clonal genetic alterations in the oral epithelium of high-risk patients. Cancer Res., 57: 5258-5260, 1997.
14. Bedi, G., Westra, W., Gabrielson, E., Koch, W., and Sidransky, D. Multiple head and neck tumors: evidence for clonal origin. Cancer Res., 56: 2484-2487, 1996.
15. Califano, J., Westra, W. H., Meninger, G., Reed, A., Koch, W., and Sidransky, D. Molecular identification of the site of origin of unknown primary squamous cell carcinoma of the head and neck, submitted for publication.
16. Spafford, M., Koch, W. M., Reed, A. L., Califano, J. A., Xu, L. H., Eisenberger, C. F., Yip, L., Leong, P. L., Wu, L., Liu, S. X., Geronimo, C., Westra, W., and Sidransky, D. Detection of head and neck squamous cell carcinoma in saliva by microsatellite analysis. J. Natl., Cancer Inst., in press, 2000.
17. Mao, L., El-Naggar, A. K., Papadimitrakopoulou, V., Shin, D. M., Shin, H. C., Fan, Y., Zhou, X., Clayman, G., Lee, J. J., Hittelman, W. N., Lippman, S. M., and Hong, W. K. Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy. J. Natl. Cancer Inst., 90: 1545-1551, 1998.